[1] Maki RG. Small Is Beautiful:Insulin-Like Growth Factors and TheirRole in Growth, Development and Cancer. J Clin Oncol. 2010;28(33):4985-4995.
[2] Micutkova L, Hermann M, Offterdinger M, et al. Analysis of the cellular uptake and nuclear delivery of insulin-like growth factor binding protein-3 in human osteosarcoma cells. Int J Cancer. 2012;130(7):1544-1557.
[3] Jogie-Brahim S, Feldman D,Oh Y. Unraveling Insulin-Like Growth Factor Binding Protein-3 Actions in Human Disease. Endocr Rev.2009;30(5):417-437.
[4] Li J, Jin D, Fu S, et al. Insulin-like growth factor binding protein-3 modulates osteoblast differentiation via interaction with vitamin D receptor. Biochem Biophys Res Commun. 2013;436(4):632-637.
[5] Silha JV, Mishra S, Rosen CJ,et al.Perturbations in Bone Formation and Resorption in Insulin-Like Growth Factor Binding Protein-3 Transgenic Mice. J Bone Miner Res. 2003; 18(10):1834-1841.
[6] Yakar S, Rosen CJ, Bouxsein ML, et al. Serum complexes of insulin-like growth factor-1 modulate skeletal integrity and carbohydrate metabolism.FASEB J.2009;23(3):709-719.
[7] Giustina A, Mazziotti G, Canalis E. Growth Hormone, Insulin-Like Growth Factors, and the Skeleton.Endocrine Rev. 2008;29(5):535-559.
[8] Liu B, Lee KW, Li H, et al. Combination Therapy of Insulin-Like Growth Factor Binding Protein-3 and Retinoid X Receptor Ligands Synergize onProstate Cancer Cell Apoptosis In vitro and In vivo.Clin Cancer Res.2005;11: 4851-4856.
[9] Bhattacharyya N, Pechhold K, Shahjee H,et al. Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus. J Biol Chem. 2006; 281(34):24588-24601.
[10] Fang P ,Hwa V, Little BM, et al. IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis. Growth Horm IGF Res. 2008;18(1):38-46.
[11] Silha JV,Gui Y, Mishra S,et al.Overexpression of gly56/gly80/gly8l-mutant insulin-like growth factor-binding protein-3 in transgenic mice.Endocrinology.2005;146: 1523-1531.
[12] Nguyen KH,Yao XH,Moulik S,et al. Human IGF binding protien-3 overexpression impairs glucose regulation in mice via an inhibition of insulin secretion.Endocrinology.2011; 152(6):2184-2196.
[13] Han SG, Park KH, Sung JS,et al.Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population. Lung Cancer.2008;62:152-161.
[14] Chen C, Lewis SK, Voigt L,et al. Prostate Carcinoma Incidence in Relation to Prediagnostic Circulating Levels of Insulin-Like Growth Factor I, Insulin-Like Growth Factor Binding Protein 3, and Insulin. Cancer. 2005;103(1):76-84.
[15] Weiss JM, Huang WY, Rinaldi S,et al. IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung,Colorectal and Ovarian Cancer Screening Trial.Int.J. Cancer.2007;121:2267-2273.
[16] Rinaldi S, Peeters PH, Berrino F,et al.IGF-I, IGFBP-3 and breast cancer risk in women: The European Prospective Investigation into Cancer and Nutrition (EPIC). Endocrine-Related Cancer.2006;13:593-605.
[17] Vatten LJ,Holly JM,Gunnell D,et al.Nested Case-Control Study of the Association of Circulating Young Women in Norway Growth Factor Binding Protein 3 with Breast Cancer in Levels of Serum Insulin-like Growth Factor I and Insulin-like. Cancer Epidemiol Biomarkers Prev.2008;17:2097-2100.
[18] Duggan C, Wang CY, Neuhouser ML, et al. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer. Int J Cancer.2013;132:1191-1200.
[19] Unsala E, Koksala D, Yurdakula AS,et al. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer. Respir Med. 2005;99(5):559-565.
[20] Yagyu K, Kikuchi S, Lin Y,et al. Lack of Association between Risk of Biliary Tract Cancer and Circulating IGF (Insulin-like Growth Factor) -I, IGF-II or IGFBP-3 (IGF-binding Protein 3): A Nested Case-control Study in a Large Scale Cohort Study in Japan (JACC Study).Asian Pacific J Cancer Prev. 2009;10: 63-67.
[21] Moon JW, Chang YS, Ahn CW,et al.Promoter 2202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk. Int J Cancer. 2006; 118:353-356.
[22] Safarinejad MR. Insulin-like growth factor binding protein-3(IGFBP-3) gene variants are associated with renal cell carcinoma. BJU Int. 2011;108(5):762-770.
[23] Hernandez W, Grenade C, Santos ER,et al.IGF-1 and IGFBP-3 gene variants influence on serum levels and prostate cancer risk in African Americans. Carcinogenesis. 2007;28(10):2154-2159.
[24] Safarinejad MR, Shafiei N, Safarinejad SH,et al.The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.Arch Toxicol.2011; 85:1209-1218.
[25] 吴琛,单耀军,邹民吉,等. IGFBP-3在真核细胞中的分泌表达及功能分析[J].生物工程学报,25,24(4):558-562.
[26] Mauras N, Pescovitz OH, Allada V,et al. Limited Efficacy of Growth Hormone (GH) during Transition of GH-Deficient Patients from Adolescence to Adulthood: A Phase III Multicenter, Double-Blind,Randomized Two-Year Trial. J Clin Endocrinol Metab. 2005;90(7):3946-3955.
[27] Westwood M, Maqsood AR, Solomon M,et al.The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.Am J Physiol Endocrinol Metab.2010;298: E467-E476.
[28] Jaffe CA,Turgeon DK,Lown K,et al.Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans.Am J Physiol Endocrinol Metab.2002;283: E1008-E1015.
[29] Stanley T. Diagnosis of Growth Hormone Deficiency in Childhood.Curr Opin Endocrinol Diabetes Obes.2012;19(1): 47-52.
[30] Quigley CA, Zagar AJ, Liu CC,et al. United States multicenter study of factors predicting the persistence of GH deficiency during the transition period between childhood and adulthood. Int J Pediatr Endocrinol. 2013;2013(1):6.
[31] Ali A, Hashim R, Khan FA,et al. Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protien-3 in diagnosis of growth hormone deficiency in short-stature children.JAyub Med Coll Abbottabad.2009;21(3):40-45.
[32] Rajpathak SN, He M, Sun Q,et al.Insulin-Like Growth Factor Axis and Risk of Type 2 Diabetes in Women.Diabetes.2012; 61:2248-2254.
[33] Lee DY, Kim MS, Hwang PH. Serum insulin-like growth factor binding protein-3 (IGFBP-3) levels are correlated with glycemic control and lipid metabolism in adolescents with type 2 diabetes.Posters / Growth Hormone & IGF Research. 2012; 22:S33-S88.
[34] Bideci A,Camurdan MO,Cinaz P,et al.Serum zinc,insulin-like growth-1 and insulin-like growth factor-binding protien-3 levels in children with type 1 diabetes mellitus. J Pediatr Endocrinol Metab.2005,18(10):1007-1011.
[35] Leger J, Marinovic D, Alberti C,et al.Lower Bone Mineral Content in Children with Type 1Diabetes Mellitus Is Linked to Female Sex, Low Insulin-Like Growth Factor Type I Levels, and High Insulin Requirement.J Clin Endocrinol Metab. 2006;91(10):3947-3953.
[36] Capoluongo E,Pitocco D,Lulli P,et al. Inverse correlation between serum free IGF-1 and IGFBP-3levels and blood pressure in patients affected with type 1diabetes. Cytokine. 2006;34(5-6):303-311.
[37] Kim MS, Lee DY. Serum insulin-like growth factor-binding protien-3 level correlated with glycemic control and lipid profiles in children and adolescents with type 1 diabetes.J Pediatr Endocrinol Metab.2014;27:393-401.
[38] Canalis E.Update in New Anabolic Therapies for Osteoporosis. J Clin Endocrinol Metab. 2010;95(4):1496- 1504.
[39] Yakar S,Courtland HW, Clemmons D. IGF-1 and Bone: New Discoveries From Mouse Models. J Bone Miner Res. 2010; 25(12):2543-2552.
[40] Silha JV,Mishra S,Rosen CJ,et al.Perturbations in Bone Formation and Resorption in Insulin-Like Growth Factor Binding Protein-3 Transgenic Mice. J Bone Miner Res. 2003;18(10):1834-1841.
[41] Amin S, Riggs BL,Atkinson EJ, et al. A Potentially Deleterious Role of IGFBP-2 on Bone Density in Aging Men and Women. J Bone Miner Res. 2004;19(7):1075-1083.
[42] Sittadjody S ,Ilangovan R, Thangasamy T,et al. Age-related changes in serum levels of insulin-like growth factor-II and its binding proteins correlate with calcaneal bone mineral density among post-menopausal South-Indian women. Clinica Chimica Acta.2012;414 :281-288.
[43] Koutroubakis IE, Zavos C, Damilakis G,et al.Role of ghrelin and growth factor binging protein-3 in the development of osteoporosis in inflammatory bowel disease.J Clin Gastroenterol. 2011;45(6):E60-E65. |